Teleo Capital Management has acquired Modersys, a pharmaceutical manufacturing intelligence platform that was previously owned by Applied Materials, Inc. The deal was announced without revealing financial terms, leaving the transaction value unclear to industry observers.

Modersys, formerly known as Smart Factory Rx, provides software solutions to biopharmaceutical, nutritional, and life sciences companies. Its platform helps clients improve yield, reduce variability, accelerate time to market, and maintain regulatory compliance across manufacturing operations.

The acquisition signals growing private equity interest in specialized life sciences technology. As pharmaceutical companies face increasing pressure to optimize production while meeting strict regulatory standards, platforms like Modersys have become more valuable to manufacturers seeking digital transformation.

Teleo Capital's purchase suggests the firm sees opportunity in the converging trends of drug manufacturing efficiency and regulatory technology. The move positions the private equity firm to capitalize on pharmaceutical companies' ongoing investments in smart manufacturing capabilities.